Trials / Completed
CompletedNCT01262144
SUV Max as Predictor of Outcome in Cervical Cancer
A Study to Evaluate the Value of SUV-Max in PET-FDG in Predicting Outcome of Surgery Vis a Vis Need for Radiotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging. However, some patients received surgery after staging and subsequently require radio/chemotherapy due to findings on operation. This study will attempt to find a correlation between SUV-Max on PET-CT and subsequent outcomes i.e. need for adjuvant therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy | Radiotherapy for cervical cancer |
Timeline
- Start date
- 2010-08-01
- First posted
- 2010-12-17
- Last updated
- 2010-12-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01262144. Inclusion in this directory is not an endorsement.